Assessing kidney health in children with horseshoe kidney condition
Nephrological Outcome and Associated Congenital Anomalies in Pediatric Patients with Horseshoe Kidney
This study looks at the kidney health of children with a horseshoe kidney to see how it affects their overall health and if they have other related health issues.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | N/A to 18 Years |
| Sex | All |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna Academic / other |
| Locations | 1 site (Bologna, Bologna) |
| Trial ID | NCT06728007 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the nephrological outcomes and associated congenital anomalies in pediatric patients diagnosed with horseshoe kidney. It involves a retrospective analysis of data collected from multiple centers, focusing on the prevalence of chronic renal failure, proteinuria, hypertension, and nephrolithiasis among affected children. The study will also explore the correlation between horseshoe kidney and other congenital anomalies, providing insights into the long-term health implications for these patients.
Who should consider this trial
Good fit: Ideal candidates for this study are children aged 0 to 18 years with a confirmed diagnosis of horseshoe kidney.
Not a fit: Patients with a definitive diagnosis of another form of congenital anomalies of the kidney and urinary tract (CAKUT) will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of the long-term health risks associated with horseshoe kidney in children, leading to improved monitoring and management strategies.
How similar studies have performed: While there have been studies on congenital kidney anomalies, this specific focus on horseshoe kidney and its nephrological outcomes is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with confirmed ultrasound and/or scintigraphic diagnosis of horseshoe kidney; * Patients with an age at first assessment of between 0 and 18 years; * Obtaining written Informed consent. Exclusion Criteria: * Patients with a definitive diagnosis of another form of CAKUT during the diagnostic pathway.
Where this trial is running
Bologna, Bologna
- IRCCS Azienda Ospedaliero-Universitaria di Bologna — Bologna, Bologna, Italy (Recruiting)
Study contacts
- Principal investigator: Claudio La Scola, MD, PhD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Claudio La Scola, MD, PhD
- Email: claudio.lascola@aosp.bo.it
- Phone: 00390512144650
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.